The number of percutaneous coronary interventions, or angioplasties, is lower in states that mandate public reporting of PCI outcomes, according to a study in the Oct. 10 issue of the Journal of the American Medical Association.
Led by Dr. Karen Joynt of the Harvard School of Public Health, Boston, researchers reviewed Medicare data for more than 100,000 patients from reporting and non-reporting states. For patients with acute myocardial infarction, their likelihood of receiving PCI in Massachusetts, Pennsylvania and New York—states with public-reporting programs— was 37.7%, compared with 42.7% in seven non-reporting states, the study said.
Read the full story at: http://bit.ly/UHpRwO
Source: Modern Healthcare